OBJECTIVE: The view that everyday function is preserved in mild cognitive impairment may be problematic. The objectives of this study were to determine the magnitude of impairment in everyday function in patients with mild cognitive impairment and Alzheimer's disease using a novel sensitive performance-based measure (the UCSD Performance-Based Skills Assessment; UPSA), contrast it with use of an informant-based measure (the Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory; ADCS-ADL), and model the relationship between cognitive measures and the performance-based measure. METHOD: Fifty cognitively normal elders, 26 patients who met criteria for amnestic mild cognitive impairment, and 22 patients who suffered from mild to moderate Alzheimer's disease were assessed on the UPSA, the ADCS-ADL, and a battery of neurocognitive tests. RESULTS: Patients with mild cognitive impairment had significant impairments on the UPSA but not on the ADCS-ADL. The magnitude of the effect size between the cognitively healthy and the mild cognitive impairment group for the UPSA was large (d=0.86). A strong and significant relationship was observed between cognitive performances in speed (R(2)=0.37), episodic memory (R(2)=0.10), and semantic processing (R(2)=0.03) and UPSA score using multiple regression models. The psychometric properties of the UPSA were acceptable, as were its sensitivity and specificity in contrasts between cognitively normal elders and patients with mild cognitive impairment and between the latter group and patients with Alzheimer's disease. CONCLUSIONS: These findings indicate that performance-based measures of function may be a sensitive tool in studies of Alzheimer's disease and mild cognitive impairment and suggest the need for a reconceptualization of the relationship between cognition and function in mild cognitive impairment so that they can be usefully aligned.
OBJECTIVE: The view that everyday function is preserved in mild cognitive impairment may be problematic. The objectives of this study were to determine the magnitude of impairment in everyday function in patients with mild cognitive impairment and Alzheimer's disease using a novel sensitive performance-based measure (the UCSD Performance-Based Skills Assessment; UPSA), contrast it with use of an informant-based measure (the Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory; ADCS-ADL), and model the relationship between cognitive measures and the performance-based measure. METHOD: Fifty cognitively normal elders, 26 patients who met criteria for amnestic mild cognitive impairment, and 22 patients who suffered from mild to moderate Alzheimer's disease were assessed on the UPSA, the ADCS-ADL, and a battery of neurocognitive tests. RESULTS:Patients with mild cognitive impairment had significant impairments on the UPSA but not on the ADCS-ADL. The magnitude of the effect size between the cognitively healthy and the mild cognitive impairment group for the UPSA was large (d=0.86). A strong and significant relationship was observed between cognitive performances in speed (R(2)=0.37), episodic memory (R(2)=0.10), and semantic processing (R(2)=0.03) and UPSA score using multiple regression models. The psychometric properties of the UPSA were acceptable, as were its sensitivity and specificity in contrasts between cognitively normal elders and patients with mild cognitive impairment and between the latter group and patients with Alzheimer's disease. CONCLUSIONS: These findings indicate that performance-based measures of function may be a sensitive tool in studies of Alzheimer's disease and mild cognitive impairment and suggest the need for a reconceptualization of the relationship between cognition and function in mild cognitive impairment so that they can be usefully aligned.
Authors: Donald R Royall; Edward C Lauterbach; Daniel Kaufer; Paul Malloy; Kerry L Coburn; Kevin J Black Journal: J Neuropsychiatry Clin Neurosci Date: 2007 Impact factor: 2.198
Authors: Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Deborah Cahn-Weiner; William Jagust; Kathleen Baynes; Charles Decarli Journal: Neuropsychology Date: 2008-07 Impact factor: 3.295
Authors: Gregory A Jicha; Joseph E Parisi; Dennis W Dickson; Kris Johnson; Ruth Cha; Robert J Ivnik; Eric G Tangalos; Bradley F Boeve; David S Knopman; Heiko Braak; Ronald C Petersen Journal: Arch Neurol Date: 2006-05
Authors: Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Kris A Johnson; David S Knopman; Bradley F Boeve; Gregory A Jicha; Robert J Ivnik; Glenn E Smith; Eric G Tangalos; Heiko Braak; Emre Kokmen Journal: Arch Neurol Date: 2006-05
Authors: K Pérès; V Chrysostome; C Fabrigoule; J M Orgogozo; J F Dartigues; P Barberger-Gateau Journal: Neurology Date: 2006-08-08 Impact factor: 9.910
Authors: N M Kemppainen; S Aalto; I A Wilson; K Någren; S Helin; A Brück; V Oikonen; M Kailajärvi; M Scheinin; M Viitanen; R Parkkola; J O Rinne Journal: Neurology Date: 2007-05-08 Impact factor: 9.910
Authors: Clifford R Jack; Val J Lowe; Matthew L Senjem; Stephen D Weigand; Bradley J Kemp; Maria M Shiung; David S Knopman; Bradley F Boeve; William E Klunk; Chester A Mathis; Ronald C Petersen Journal: Brain Date: 2008-02-07 Impact factor: 13.501
Authors: Brent T Mausbach; Phillip D Harvey; Sherry R Goldman; Dilip V Jeste; Thomas L Patterson Journal: Schizophr Bull Date: 2007-03-06 Impact factor: 9.306
Authors: Lea Vella; Thomas L Patterson; Philip D Harvey; Margaret McNamara McClure; Brent T Mausbach; Michael J Taylor; Elizabeth W Twamley Journal: Psychiatry Res Date: 2017-06-12 Impact factor: 3.222
Authors: Caroline L Lassen-Greene; Kayla Steward; Ozioma Okonkwo; Ellen Porter; Michael Crowe; David E Vance; H Randall Griffith; Karlene Ball; Daniel C Marson; Virginia G Wadley Journal: J Geriatr Psychiatry Neurol Date: 2017-07 Impact factor: 2.680
Authors: Terry E Goldberg; Richard S E Keefe; Robert S Goldman; Delbert G Robinson; Philip D Harvey Journal: Neuropsychopharmacology Date: 2010-01-20 Impact factor: 7.853
Authors: A S Atkins; I Stroescu; N B Spagnola; V G Davis; T D Patterson; M Narasimhan; P D Harvey; R S E Keefe Journal: J Prev Alzheimers Dis Date: 2015-06